WASHINGTON, D.C.—House Financial Services Committee member, Rep. Bryan Steil (WI-01), introduced H.R. 7661, the Coronavirus EGC Extension Act to extend the initial public offering (IPO) on-ramp for Emerging Growth Companies (EGCs) during the ongoing coronavirus pandemic. This on-ramp gives EGCs the opportunity to access public capital markets to fund critical investment and growth by granting them appropriately…

Read More

Says biopharma researchers and scientists stand ready to support real solutions that will address patient drug costs, continue lifesaving science WASHINGTON–(BUSINESS WIRE)–Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a statement today warning that an executive order to adopt foreign price controls on certain prescription medicines could “cripple” companies…

Read More

Atlanta-based pharmaceutical company Inhibikase Therapeutics Inc. is planning to raise $18 million in an initial public stock offering. Inhibikase is a clinical stage pharmaceutical company developing therapeutics for Parkinson’s Disease, or PD, and related disorders. PD is the second most prevalent neurodegenerative disease of the central nervous system, with 7 million to 10 million cases…

Read More

SEC Issues Supplemental Guidance Concerning Proxy Voting Responsibilities of Investment Advisers Washington D.C., July 22, 2020 — The Securities and Exchange Commission today voted to adopt amendments to its rules governing proxy solicitations designed to ensure that clients of proxy voting advice businesses have reasonable and timely access to more transparent, accurate and complete information…

Read More

As a COVID-19 survivor, Kevin Weinrich could be a key to helping others fight the disease by simply donating his blood. The idea is the antibodies in Weinrich’s plasma can help a sick patient fend off the infection. The 58-year-old computer programmer has donated his plasma, the antibody-rich liquid portion of his blood, four times over…

Read More

In its latest action to help ensure the widespread availability of testing to detect and contain the coronavirus, the Advanced Medical Technology Association (AdvaMed) today announced the creation of a comprehensive, national COVID-19 diagnostic supply registry to help state and federal governments in their pandemic responses. The national registry is being launched in partnership with…

Read More

While the disproportionate impact of COVID-19 on Black and Hispanic Americans is no secret, federal officials have launched studies of the disparity that they hope will better prepare the country for the next great epidemic. The National Institutes of Health began the ambitious “All of Us” research project in 2018 with the goal of enrolling…

Read More

Metaclipse, a late-stage biotechnology company developing next-generation vaccines with a particular focus on treatments for the elderly, has been awarded $2.2 million by the National Institute of Allergy and Infectious Diseases (NIAID) to support its efforts to develop a COVID-19 vaccine. This first stage of funding from NIAID is critical to enable ongoing development of…

Read More

The following letter provides BIO’s feedback on a number of regulatory proposals by the Centers for Medicare & Medicaid Services that would ease barriers to use of value-based purchasing arrangements within Medicaid and commercial plans, broaden definitions of line extension, and place limits on calculations of patient assistance programs in Medicaid Best Price. Download comments…

Read More